At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

T-bet is a transcription factor, one of the control proteins in the cell nucleus that can turn specific groups of genes on ...

Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on ...